OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us," or "our"), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a strategic partnership with Atropos Health, the creator of real-world evidence for clinical decision-making under a multi-year agreement. The partnership adds OneMedNet's regulatory decision-grade data to Atropos’ platform and customer offerings under a fee arrangement adding to our Annual Recurring Revenue (ARR).